Previous Section Index Home Page

31 Oct 2006 : Column 354W—continued


MS

Mr. Jim Cunningham: To ask the Secretary of State for Health what assistance is available to NHS patients diagnosed with multiple sclerosis. [97709]

Mr. Ivan Lewis: People diagnosed with multiple sclerosis have access to the full range of health and social care as detailed in the national service framework for long-term conditions. In addition, all patients living with multiple sclerosis have access to a wide range of medications to help manage the symptoms associated with this disease. These include drugs for the relief of pain, depression, spasticity and bladder problems.

Multiple Myeloma

Mr. Keetch: To ask the Secretary of State for Health what treatments are currently licensed for multiple myeloma in the UK; what treatments for multiple myeloma are currently provided by the NHS; whether thalidomide is licensed for the treatment of multiple myeloma; and if she will make a statement. [96641]

Ms Rosie Winterton: Treatments licensed for the treatment of multiple myeloma are listed in the British National Formulary, which can be found at www.bnf.org.

It will be for clinicians, in discussion with patients, to determine treatments for a patient's condition. Treatments that have been positively appraised by National Institute for Health and Clinical Excellence
31 Oct 2006 : Column 355W
(NICE) must be funded by primary care trusts within three months of publication of guidance, if the patient concerned is eligible.

Where NICE guidance is not available, PCTs should continue with local arrangements for the managed introduction of new technologies. These arrangements should involve an assessment of all the available evidence. Funding for such treatments should not be withheld simply because of an absence of guidance from NICE.

Thalidomide for the treatment of multiple myeloma is not licensed. Thalidomide can be given to particular patients if their clinician thinks they might benefit; this is called a named patient basis, and the PCT concerned agrees to fund it. Thalidomide may also be given to people taking part in research trials.

NHS Cancer Plan

Mr. Kevan Jones: To ask the Secretary of State for Health how much money was allocated to the University Hospital North Durham for capital expenditure under the NHS cancer plan; and what capital equipment has been purchased by the hospital under the plan. [97152]

Ms Rosie Winterton [holding answer 26 October 2006]: The University Hospital North Durham was allocated £0.679 million under the NHS Cancer Plan investment programme for the purchase of an additional CT scanner and associated building works. A delivery date for the scanner will be agreed shortly.

NHS Finance

Mr. Jim Cunningham: To ask the Secretary of State for Health what capital expenditure there has been within the NHS in Coventry since May 1997; and if she will make a statement. [97708]

Andy Burnham: The following table shows total capital expenditure by national health service bodies in Coventry from 1998-99 to 2004-05, which are the only years for which figures are available. These figures exclude private finance initiative (PFI) and local improvement finance trust (LIFT) schemes.

Total capital expenditure by NHS bodies in Coventry
Expenditure

1998-99

21,626,000

1999-2000

8,203,000

2000-01

9,871,000

2001-02

12,838,000

2002-03

8,181,000

2003-04

21,105,000

2004-05

22,516,000

Sources:
Audited accounts of Coventry health authority 1998-99 to 2001-02
Audited summarisation schedules of Coventry teaching primary care trust 2002-03 to 2004-05
Audited summarisation schedules of Walsgrave hospital NHS trust 1998-99 and 1999-2000
Audited summarisation schedules of university hospitals Coventry and Warwickshire NHS trust 2000-01 to 2004-05
Audited summarisation schedules of Coventry healthcare NHS trust 1998-99 to 2001-02
Audited summarisation schedules of Coventry and Warwickshire ambulance NHS trust 2003-04 and 2004-05

31 Oct 2006 : Column 356W

The following table shows capital expenditure on PFI and LIFT schemes by Coventry teaching PCT from 2003-04 to 2006-07. These figures were obtained from NHS West Midlands.

Coventry teaching primary care trust—capital expenditure on LIFT/PFI
LIFT PFI

2003-04

LIFT Enabling Funds—Purchase of Land and Associated Costs

1,020,212

2004-05

PFI Residual Interest

159,000

LIFT Enabling Funds—Purchase GP Premises

874,815

MHU—PFI Equipment (including Car Park Barrier)

203,593

MHU—PFI IT Equipment

111,603

MHU—Boundary Fence

11,620

MHU—Pharmacy (Library Option)

13,591

2005-06

PFI Residual Interest

165,000

Purchase of LIFT Co Equity

130,462

Longford Furniture and Equipment

120,500

Keresley Furniture and Equipment

20,964

Longford Switchboard

33,591

MHU—PFI IT Equipment (Library Management System)

10,000

2006-07 (to 26 October 2006)

PFI Residual Interest

171,000

Total

2,200,544

845,407


In addition, the new £400 million Walsgrave hospital PFI opened in Coventry in July 2006.

NHS Recruitment

Helen Jones: To ask the Secretary of State for Health what information her Department collects on (a) vacant posts, (b) posts which are frozen and (c) qualified staff who are seeking work in the NHS. [98699]

Ms Rosie Winterton: The Information Centre for Health and Social Care collects information as at 31 March about posts that have been vacant for three months or more that trusts and primary care trusts are actively trying to recruit to.

The general practitioner practice vacancies survey produces an estimated three-month vacancy figure from a sample of 2,000 randomly selected GP practices in England, stratified by strategic health authority.

Information on the number of frozen posts is not collected centrally.

Information about the number of qualified staff who are seeking work in the national health service is not collected centrally.

NHS Savings Plans

Mr. Hayes: To ask the Secretary of State for Health what (a) staff reductions, (b) ward closures, (c) asset
31 Oct 2006 : Column 357W
sales and (d) assets to be reduced in use are part of the savings planned at (i) Epsom, (ii) Ealing, (iii) St. George's London, (iv) Westminster, (v) Hammersmith, (vi) Hillingdon and (vii) St. Helier London hospitals. [96236]

Andy Burnham: This information is not held centrally.

NHS Training Budgets

Helen Jones: To ask the Secretary of State for Health how many health authorities are planning to reduce their spending on training over the next three years; and what (a) the percentage reduction planned and (b) the cash amount of such a reduction is in each case. [95659]

Ms Rosie Winterton: As budgets for 2007-08 and beyond have not yet been set, it is too early to say what the priorities of local delivery plans for 2007-08 onwards will be.

NICE

Sandra Gidley: To ask the Secretary of State for Health when she expects all NHS trusts to implement fully the National Institute for Health and Clinical Excellence guidance on infertility. [95275]

Caroline Flint: The primary responsibility for implementing the National Institute for Health and Clinical Excellence's guidelines, including the rate of implementation, rests with the national health service at local level. Local policies on the provision of treatment services reflect local health needs and priorities. We are supporting a new project by the voluntary organisation Infertility Network UK on ways in which it can work with primary care trusts (PCTs) to help ensure that fertility patients’ voices are heard when decisions about the provision of services are made at local level. We have asked PCTs to co-operate with this project.

Non-governmental Public Bodies

Dr. Cable: To ask the Secretary of State for Health what the (a) administration costs and (b) total number of staff of (i) the Healthcare Commission, (ii) the Commission for Social Care Inspection, (iii) the Office of the Independent Regulator of Foundation Trusts and (iv) the Medicines and Healthcare Products Regulatory Agency were in each of the last three years for which figures are available. [94948]

Mr. Ivan Lewis: The information is as follows.

The administrative costs for:


31 Oct 2006 : Column 358W
£ million

Healthcare Commission

2003-04

(1)

2004-05

68.994

2005-06

67.888

Commission for Social Care Inspection

2003-04

109.86

2004-05

112.771

2005-06

99.07

Office of the Independent Regulator of Foundation Trusts

2003-04

3.408

2004-05

14.81

2005-06

15.879

Medicines and Healthcare Products Regulatory Agency

2003-04

11.983

2004-05

10.982

2005-06

10.982

(1) The Healthcare Commission was not in existence

The total number of staff expressed as whole-time equivalents for:

Whole time-equivalents

Healthcare Commission

2003-04

(1)

2004-05

771

2005-06

771

Commission for Social Care Inspection

2003-04

2,589

2004-05

2,622

2005-06

2,492

Office of the Independent Regulator of Foundation Trusts

2003-04

2

2004-05

33

2005-06

51

Medicines and Healthcare Products Regulatory Agency

2003-04

747

2004-05

806

2005-06

827

(1) The Healthcare Commission was not in existence

Next Section Index Home Page